Mary R. Rabey
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Identifying Patients With High-Risk Stage I NSCLC Using a Tumor-Informed Plasma ctDNA Assay.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 27, 2026
Circulating-tumour DNA (ctDNA) in NSCLC: mechanisms, evidence and the future of MRD detection.
Journal: BMJ oncology
Published: October 06, 2025
Liquid Biopsy in Lung Cancer: Tracking Resistance to Targeted Therapies.
Journal: Cancers
Published: September 24, 2025
Biomarker Testing Among Patients With Nonsquamous NSCLC Across Three Time Periods and Three Testing Platforms-A Brief Report.
Journal: JTO clinical and research reports
Published: August 15, 2025
Preoperative circulating tumor DNA detection and occult lymph node metastases in clinical stage I lung cancer: The lung DETECT study.
Journal: JTCVS open
Published: May 31, 2025
Impact of the COVID-19 Pandemic on Diagnosis and Multidisciplinary Treatment of NSCLC in Ontario, Canada.
Journal: JTO clinical and research reports
Published: April 10, 2025
2024 Canadian Surgery Forum: Sept. 25-28, 2024.
Journal: Canadian journal of surgery. Journal canadien de chirurgie
Published: November 28, 2024
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer-A Single-Center Experience.
Journal: Current oncology (Toronto, Ont.)
Published: June 04, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026